Ye Hwang Cheong

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Dong-A Pharmaceutical (South Korea)(Current)

Ye Hwang Cheong is an author at Dong-A Pharmaceutical (South Korea) specializing in dipeptidyl peptidases, peptide drug discovery, and type 2 diabetes pharmacotherapy.

Publications per year

2011–2022

Publications

Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Heung Jae Kim, Woo Young Kwak, Jong Pil Min et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression

Mi-Kyung Kim, Ye Hwang Cheong, Seung Ho Lee et al. · Biomedicine & Pharmacotherapy · 2021 · 12 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Diesel exhaust particle exposure accelerates oxidative DNA damage and cytotoxicity in normal human bronchial epithelial cells through PD-L1

Minji Kwon, Jiwoo Jung, Hee Sun Park et al. · Environmental Pollution · 2022 · 10 citations

Pharmacy, Environmental Sciences, Toxicology +16

1–3 of 3